CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,240 | $445.29 | $552K | 2,890 |
| 2025-10-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −860 | $448.89 | $386K | 2,030 |
| 2025-10-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −900 | $454.14 | $409K | 1,130 |
| 2025-10-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $456.52 | $457K | 130 |
| 2025-10-08 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 202,000 | ||
| 2025-10-07 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $450.31 | $450K | 3,130 |
| 2025-10-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $451.87 | $904K | 1,130 |
| 2025-10-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $453.28 | $453K | 130 |
| 2025-10-07 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 206,000 | ||
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −400 | $449.82 | $180K | 14,225 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −800 | $450.97 | $361K | 13,425 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −11,975 | $452.03 | $5.4M | 1,450 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,250 | $453.16 | $566K | 200 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −200 | $253.98 | $51K | 0 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −300 | $450.06 | $135K | 7,575 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −500 | $451.01 | $226K | 7,075 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −6,625 | $452.04 | $3.0M | 450 |
Page 194 of 214 · 4,273 trades